GKOS vs LNG
GKOS: Glaukos is a high-growth ophthalmology leader transforming the standard of care for glaucoma and corneal diseases through novel micro-invasive surgeries and sustained-release drug delivery systems. LNG: Cheniere Energy is the largest producer of LNG in the United States, providing a critical global supply chain for liquefied natural gas infrastructure.
Side-by-side fundamentals
| Metric | GKOS | LNG | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $237.60 | $330.32 | |
| Market cap | $14.1B | $67.5B | |
| P/E as of 2026-10-30 | n/a | 23.51 | |
| Net margin FY2025, SEC XBRL | -37.0% | +26.7% | LNG higher |
| Gross margin FY2025, SEC XBRL | +55.7% | n/a | |
| Operating margin FY2025, SEC XBRL | -39.3% | +45.6% | LNG higher |
| ROE FY2025, SEC XBRL | -28.6% | +41.2% | LNG higher |
| ROA FY2025, SEC XBRL | -21.0% | +11.1% | LNG higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-09-30 | n/a | 3.65 | |
| Revenue growth (YoY) FY2025, SEC XBRL | +32.3% | +27.2% | GKOS higher |
| Revenue CAGR (3y) SEC XBRL | +21.5% | -15.8% | GKOS higher |
| Dividend yield as of 2026-09-03 | n/a | 0.68% | |
| Dividend streak (yrs) SEC XBRL | 0 | 4 | LNG higher |
| Beta as of 2026-09-03 | 1.23 | 0.30 | |
| 1-year return as of 2026-10-30 close | +170.6% | +56.2% | GKOS higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.